
Models & ResearchThe Neuron · 17m ago
Merck collaborates with Isomorphic Labs to discover cancer treatments
Pharmaceutical company Merck has entered a strategic research partnership with Alphabet subsidiary Isomorphic Labs. The alliance will combine proprietary laboratory data from Merck with computational models to identify new oncology drug candidates. The deal reflects ongoing pharmaceutical interest in applying machine learning to molecular discovery.
MerckIsomorphic LabsAlphabet
Read the original